Product Overview
LS-008 | T27853 | TargetMol Chemicals
CAS: T27853
Smiles: NA
Formula: N/A
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: LS-008, a PLK/PI3K dual inhibitor, may be used for treating cancer.
Molecular Weight: N/A
-
Guides
- MMP
- Eridan™
- Image Analysis
- Collecting duct carcinoma (CDC)
- Immunohistochemistry and In Situ Hybridization
- Immunohistochemistry in the Diagnosis of Whipple's disease
- In Situ Hybridization
- KATP
- Multiple Labeling
- MCM2
- p21
- Metallothionein
- Polysomy of chromosome 17 in breast cancer
- Stem Cell Catalog
- Survivin
- VEGF-C
- XmatrxTM Automated Staining System
- ALCAM (CD166)
- c-kit (CD117)
- S100A7 (psoriasin)
- CD155/PVR plays a key role in cell motility during tumor cell invasion and migration
- Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells
- Diagnostic Immunohistochemistry
- MCM
- DAX-1
- Any Test, Any Time
- A Global Search Engine for Antibodies
- Autofluorescence
- Human Antibody Initiative
- Chromogenic in situ hybridization (CISH)
- Connexin
- EnzMet (SISH)
- ExactAntigen
- Exploring the functional neuroanatomy of neuronal nicotinic acetylcholine receptors
- Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
- Frozen Sections
- Human CD57+ germinal center-T cells
- Human Protein Atlas
- Immunofluorescence
- Immunohistochemistry
- Immunohistochemistry Positive Control Tissue
- Multiple Antigen Labeling Guide
- OptiView DAB IHC Detection Kit
- PLA™ Proximity Ligation Assay technology
- Quality Antibodies for research in Zebrafish
- Phospho-STAT5
- HER2 and p53 in breast cancer
- Tyramide Signal Amplification
- RNAscope®
